{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:45:05Z","timestamp":1778838305232,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.pathol.2017.12.340","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T19:57:09Z","timestamp":1523995029000},"page":"402-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunohistochemical CD271 expression correlates with melanoma progress in a case-control study"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7859-6321","authenticated-orcid":false,"given":"Patricia Switten","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikke","family":"Riber-Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torben","family":"Steiniche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2017.12.340_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2017.12.340_bib2","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2017.12.340_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pathol.2017.12.340_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1755-148X.2007.00427.x","article-title":"Cancer stem cells and human malignant melanoma","volume":"21","author":"Schatton","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.pathol.2017.12.340_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nature09161","article-title":"Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271","volume":"466","author":"Boiko","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2017.12.340_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2008.10.039","article-title":"Stem cells in melanoma development","volume":"279","author":"Sabatino","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pathol.2017.12.340_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/labinvest.2013.116","article-title":"Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?","volume":"94","author":"Lee","year":"2014","journal-title":"Lab Invest"},{"key":"10.1016\/j.pathol.2017.12.340_bib8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cell.2009.08.017","article-title":"Heterogeneity in cancer: cancer stem cells versus clonal evolution","volume":"138","author":"Shackleton","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2017.12.340_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cell.2008.02.007","article-title":"Mechanisms of asymmetric stem cell division","volume":"132","author":"Knoblich","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2017.12.340_bib10","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","article-title":"Cancer stem cells\u2013perspectives on current status and future directions: AACR workshop on cancer stem cells","volume":"66","author":"Clarke","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2017.12.340_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/00313020903488773","article-title":"The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis","volume":"42","author":"Hemmings","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2017.12.340_bib12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature07567","article-title":"Efficient tumour formation by single human melanoma cells","volume":"456","author":"Quintana","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2017.12.340_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.10.012","article-title":"Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized","volume":"18","author":"Quintana","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2017.12.340_bib14","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","article-title":"A\u00a0tumorigenic subpopulation with stem cell properties in melanomas","volume":"65","author":"Fang","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2017.12.340_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/modpathol.3800720","article-title":"Increased expression of stem cell markers in malignant melanoma","volume":"20","author":"Klein","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2017.12.340_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13000-015-0331-z","article-title":"Prognostic significance of ALCAM (CD166\/MEMD) expression in cutaneous melanoma patients","volume":"10","author":"Donizy","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.pathol.2017.12.340_bib17","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1158\/0008-5472.CAN-10-3997","article-title":"Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth","volume":"71","author":"Civenni","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2017.12.340_bib18","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jss.2010.03.043","article-title":"Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease","volume":"163","author":"Sharma","year":"2010","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.pathol.2017.12.340_bib19","first-page":"22","article-title":"p75 neurotrophin receptor in the skin: beyond its neurotrophic function","volume":"4","author":"Pincelli","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.pathol.2017.12.340_bib20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mt.2012.27","article-title":"Targeting CD20 in melanoma patients at high risk of disease recurrence","volume":"20","author":"Pinc","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.pathol.2017.12.340_bib21","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.18632\/oncotarget.1967","article-title":"CD271 is an imperfect marker for melanoma initiating cells","volume":"5","author":"Cheli","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2017.12.340_bib22","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1073\/pnas.1009069108","article-title":"Eradication of melanomas by targeted elimination of a minor subset of tumor cells","volume":"108","author":"Schmidt","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2017.12.340_bib23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2017.12.340_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/modpathol.2012.188","article-title":"Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I\/II melanoma","volume":"26","author":"Nielsen","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2017.12.340_bib25","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/jid.2011.159","article-title":"From cancer stem cells to tumor maintenance in melanoma","volume":"131","author":"Fukunaga-Kalabis","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pathol.2017.12.340_bib26","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1158\/1078-0432.CCR-08-0644","article-title":"Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme","volume":"14","author":"Pallini","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2017.12.340_bib27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/modpathol.2009.163","article-title":"Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis","volume":"23","author":"Al Dhaybi","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2017.12.340_bib28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.humpath.2014.01.009","article-title":"Automated quantification of MART1-verified Ki67 indices: useful diagnostic aid in melanocytic lesions","volume":"45","author":"Nielsen","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2017.12.340_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.5858\/arpa.2011-0360-OA","article-title":"Automated quantification of MART1-verified Ki67 indices by digital image analysis in melanocytic lesions","volume":"136","author":"Nielsen","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2017.12.340_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13000-016-0484-4","article-title":"Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3\/MART1 dual-stained stage I\/II melanoma","volume":"11","author":"Nielsen","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.pathol.2017.12.340_bib31","first-page":"396076","article-title":"Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance","volume":"2011","author":"Moore","year":"2011","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.pathol.2017.12.340_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.pathol.2017.12.340_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/ced.12928","article-title":"Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma","volume":"41","author":"Gambichler","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.pathol.2017.12.340_bib34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/bjd.13301","article-title":"CD271 is expressed in melanomas with more aggressive behaviour, with correlation of characteristic morphology by in\u00a0vivo reflectance confocal microscopy","volume":"172","author":"Beretti","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pathol.2017.12.340_bib35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PAI.0b013e3182910a3d","article-title":"Tumor stem cells (CD271, c-kit, SOX10) in melanomas: prognostic and outcome implications","volume":"22","author":"Mohamed","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.pathol.2017.12.340_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/1097-0215(20010120)95:1<73::AID-IJC1013>3.0.CO;2-S","article-title":"Expression of melan-A\/MART-1 antigen as a prognostic factor in primary cutaneous melanoma","volume":"95","author":"Berset","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2017.12.340_bib37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/labinvest.2011.50","article-title":"Melanoma stem cells: not rare, but well done","volume":"91","author":"Girouard","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.pathol.2017.12.340_bib38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0002-9440(10)64943-7","article-title":"Activated leukocyte cell adhesion molecule\/CD166, a marker of tumor progression in primary malignant melanoma of the skin","volume":"156","author":"van Kempen","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2017.12.340_bib39","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/jid.2014.454","article-title":"CD271 mediates stem cells to early progeny transition in human epidermis","volume":"135","author":"Truzzi","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pathol.2017.12.340_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/1346-8138.13048","article-title":"Age-related decrease in CD271(+) cells in human skin","volume":"43","author":"Akamatsu","year":"2016","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.pathol.2017.12.340_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.dsi.2014.05.002","article-title":"Keratinocytes regulate the function of melanocytes","volume":"32","author":"Hirobe","year":"2014","journal-title":"Dermatologica Sinica"},{"key":"10.1016\/j.pathol.2017.12.340_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/path.861","article-title":"Expression of neurotrophins and their receptors in pigment cell lesions of the skin","volume":"194","author":"Innominato","year":"2001","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2017.12.340_bib43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/DAD.0b013e318214ae8a","article-title":"Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions","volume":"33","author":"Shanesmith","year":"2011","journal-title":"Am J Dermatopathol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302517303136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302517303136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T13:34:40Z","timestamp":1561210480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302517303136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0031302517303136"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2017.12.340","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemical CD271 expression correlates with melanoma progress in a case-control study","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2017.12.340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}